1. Home
  2. TCX vs PLX Comparison

TCX vs PLX Comparison

Compare TCX & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tucows Inc.

TCX

Tucows Inc.

SELL

Current Price

$9.62

Market Cap

167.0M

Sector

Technology

ML Signal

SELL

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

SELL

Current Price

$2.75

Market Cap

182.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TCX
PLX
Founded
1992
1993
Country
Canada
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.0M
182.9M
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
TCX
PLX
Price
$9.62
$2.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
49.1K
★ 767.5K
Earning Date
11-05-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.27
Revenue
★ $362,275,000.00
$52,744,000.00
Revenue This Year
$26.83
$55.77
Revenue Next Year
$10.04
N/A
P/E Ratio
★ N/A
$10.30
Revenue Growth
★ 6.76
N/A
52 Week Low
$8.45
$1.60
52 Week High
$25.17
$3.19

Technical Indicators

Market Signals
Indicator
TCX
PLX
Relative Strength Index (RSI) 42.44 57.33
Support Level $8.62 $2.59
Resistance Level $10.97 $2.85
Average True Range (ATR) 0.52 0.09
MACD -0.04 -0.01
Stochastic Oscillator 34.50 73.83

Price Performance

Historical Comparison
TCX
PLX

About TCX Tucows Inc.

Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. The company generates key revenue from Canada and USA.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: